undamentalytics Newsletter

Paslick P. Martin: insider trades

Officer at HCA Healthcare. No open-market purchases and 16 sales not made under a pre-set plan, reported from February 27, 2013 to February 1, 2023.

What happened after Paslick P. Martin’s sales?

After their sales, the shares moved +13.8% against the index over 12 months on average (a negative figure means selling was the right call); 31% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Paslick P. Martin: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 16 +1.6% +3.5% 38% 7 0.09 0.93 No reliable evidence
Sales, 12 months after the report 16 +13.8% +6.7% 31% 7 0.47 0.66 No reliable evidence
Sales, 12 months after the trade 16 +13.7% +4.7% 44% 7 0.40 0.70 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
HCA Healthcare HCA SVP and CIO016February 27, 2013February 1, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 1, 2023February 1, 2023 HCA Sale $256,950 +10.3%+1.5%−2.7%
July 29, 2021July 27, 2021 HCA Sale $1,866,500 −3.7%−9.3%−9.3%
May 6, 2021May 6, 2021 HCA Sale $1,592,324 +13.9%+10.2%+7.9%
November 17, 2020November 13, 2020 HCA Sale $619,778 +6.7%+28.5%+31.0%
November 9, 2020November 9, 2020 HCA Sale $584,580 +4.8%+29.8%+34.8%
November 5, 2020November 3, 2020 HCA Sale $236,428 +14.9%+44.5%+45.0%
October 29, 2020October 27, 2020 HCA Sale $113,475 +16.7%+61.3%+53.5%
August 13, 2020August 11, 2020 HCA Sale $30,638 +2.3%+49.8%+49.2%
August 10, 2020August 6, 2020 HCA Sale $378,699 +5.1%+49.2%+56.0%
February 21, 2020February 19, 2020 HCA Sale $775,050 −15.7%+3.3%−0.6%
February 13, 2017February 9, 2017 HCA Sale $1,880,754 −3.4%+1.8%+1.4%
November 1, 2016October 28, 2016 HCA Sale $2,836,755 +1.6%−23.5%−24.7%
May 6, 2016May 4, 2016 HCA Sale $1,430,280 −12.3%−14.8%−14.3%
August 11, 2015August 7, 2015 HCA Sale $1,242,000 −23.2%−22.1%−23.8%
May 15, 2015May 13, 2015 HCA Sale $137,214 +13.4%−2.8%−0.5%
February 27, 2013February 27, 2013 HCA Sale $912,500 −5.2%+12.7%+15.7%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Paslick P. Martin traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.